Date de décision2016-03-22
Code produitFCG
Comité consultatifPolitique : medical-regulatory-v1.
GUIDELINES FOR MEDICAL DEVICE REGULATION
1. Introduction
1.1 This document outlines the regulatory requirements for medical devices as established by the U.S. Food and Drug Administration (FDA).
1.2 These guidelines are intended to assist companies in understanding and complying with the applicable regulations for the marketing and sale of medical devices in the United States.
2. Classification of Medical Devices
2.1 Medical devices are classified into three classes (I, II, and III) based on the risk they pose to the user.
2.2 Class I devices are considered lowest risk and typically require a 510(k) submission to the FDA.
2.3 Class II devices are considered moderate risk and may require a Pre-Market Approval (PMA) or a 510(k) submission.
2.4 Class III devices are considered highest risk and generally require a PMA submission.
3. 510(k) Submission
3.1 A 510(k) submission is a pre-market notification submitted to the FDA to demonstrate that a new medical device is substantially equivalent to an existing device that is legally marketed in the United States.
3.2 The 510(k) submission must include a detailed description of the device, its intended use, and the data to support its safety and effectiveness.
4. Pre-Market Approval (PMA)
4.1 A Pre-Market Approval (PMA) is a submission required for certain high-risk medical devices.
4.2 The PMA submission must include extensive clinical data, including the results of clinical trials, to demonstrate the safety and effectiveness of the device.
5. Investigational Device Exemptions (IDE)
5.1 An Investigational Device Exemption (IDE) is a regulatory pathway that allows for the investigation of a new medical device in clinical studies.
5.2 An IDE submission must include a detailed description of the device, the study protocol, and the rationale for the investigation.
6. Good Manufacturing Practices (GMP)
6.1 Good Manufacturing Practices (GMP) are regulations that ensure the quality of medical devices.
6.2 Companies must comply with GMP requirements to ensure that their devices are safe and effective.
7. Labeling and Advertising
7.1 Labeling and advertising of medical devices must comply with FDA regulations.
7.2 Companies must ensure that their labeling and advertising are accurate, clear, and not misleading.
8. Post-Market Surveillance
8.1 Post-market surveillance is a process used to monitor the safety and effectiveness of medical devices after they have been marketed.
8.2 Companies are required to report any adverse events or changes in the device's performance to the FDA.
9. Conclusion
9.1 These guidelines provide a comprehensive overview of the regulatory requirements for medical devices in the United States.
9.2 Companies are encouraged to consult with the FDA or a regulatory expert to ensure compliance with all applicable regulations.
DécisionÉquivalence substantielle
Résumé du dispositif
Single Use Aspiration Needle NA-U401SX is the device name listed in this FDA 510(k) record. The listed applicant is Olympus Medical Systems Corp.. It received FDA 510(k) clearance on 2016-03-22 under 510(k) number K160098. The device is classified under product code FCG. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
Questions fréquentes
What is the Single Use Aspiration Needle NA-U401SX?
Single Use Aspiration Needle NA-U401SX is a medical device that received FDA 510(k) clearance on 2016-03-22. The listed applicant is Olympus Medical Systems Corp.. The 510(k) number is K160098.
When did Single Use Aspiration Needle NA-U401SX receive FDA 510(k) clearance?
Single Use Aspiration Needle NA-U401SX received FDA 510(k) clearance on 2016-03-22, under 510(k) number K160098.
Who is the listed applicant for Single Use Aspiration Needle NA-U401SX?
L'enregistrement 510(k) de la FDA liste Olympus Medical Systems Corp. comme demandeur. Cela ne constitue pas en soi l'établissement du fabricant du dispositif.
What is the FDA product code for Single Use Aspiration Needle NA-U401SX?
The FDA product code for Single Use Aspiration Needle NA-U401SX is FCG.
Essais cliniques associés
Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.
Autres dossiers indiquant Olympus Medical Systems Corp. en tant que demandeur
Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.
K262079Tête de caméra 4K OLYMPUS CH-S700-08-LB
Réglementation médicale :
- FDA : Food and Drug Administration
- 510(k) : Premarket Notification
- PMA : Premarket Approval
- NCT : ClinicalTrials.gov Identifier
- PMID : PubMed Identifier
- Identifiants et URLs : conservés tels quels
Politique : medical-regulatory-v1K254056THUNDERBEAT 5 mm, 45 cm, Poignée actionnée à l'avant Type S (TB-0545FCS); THUNDERBEAT 5 mm, 35 cm, Poignée actionnée à l'avant Type S (TB-0535FCS); THUNDERBEAT 5 mm, 20 cm, Poignée actionnée à l'avant Type S (TB-0520FCS)K260580Applicateur de Clip à Utilisation Unique et Rechargeable (HX-810LR, HX-810UR); Clip (HX-610-090, HX-610-135); Clip Long (HX-610-090L, HX-610-135L); Clip Court (HX-610-090S, HX-610-135S); Clip Très Court (HX-610-135XS)K252341EVIS EXERA III BRONCHOVIDEOSCOPE (OLYMPUS BF-Q190); EVIS EXERA III BRONCHOVIDEOSCOPE (OLYMPUS BF-H190); EVIS EXERA III BRONCHOVIDEOSCOPE (OLYMPUS BF-1TH190)K251807Électrochirurgicaux à usage unique pour la hémostase Forceps FD-410LR, FD-411UR, FD-412LRK253646Couverture distale à usage unique MAJ-2315 (MAJ-2315) Voir tous les 80 dispositifs →
Dispositifs connexes (Code : FCG)
Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.
Source officielle
Voir dans la base de données FDA →Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.